Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mentor Capital Inc MNTR

Mentor Capital, Inc. is a public energy company. The Company targets the classic energy sectors of oil and gas, coal, uranium, and their related operations, with already established cash flows, especially through royalty payments. Its classic energy segment includes the fair value of securities investments in oil and gas through Exxon Mobil Corp. (XOM) stock, Occidental Petroleum Corp. (OXY... see more

Recent & Breaking News (OTCQB:MNTR)

Mentor Capital Enters Medical Marijuana Field to Combat Cancer Wasting

Business Wire September 30, 2013

Mentor Capital, Inc. Funds Completion of 12.5% Stock Buyback

Business Wire September 5, 2013

OtcbbJournal.com, One of the Most Successful Groups of Micro-Cap Traders, Issues New Research Reports

Marketwired July 23, 2013

Mentor Capital Cancer Immunotherapy Index Gains 31% During First Half of 2013

Business Wire July 19, 2013